article Drug Discovery Experiment Automation

Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling

Filipp Gusev, Evgeny Gutkin, Maria G. Kurnikova, Olexandr Isayev

J. Chem. Inf. Model. Vol. 63(2) pp. 583–594 2023 44 citations

Highlight

Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling.

Keywords

Cite This Paper

@article{Gusev2023,
  author = {Gusev, Filipp and Gutkin, Evgeny and Kurnikova, Maria G. and Isayev, Olexandr},
  title = {Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling},
  year = {2023},
  journal = {J. Chem. Inf. Model.},
  volume = {63},
  number = {2},
  pages = {583--594},
  doi = {10.1021/acs.jcim.2c01052},
  keywords = {active learning, drug design, binding free energy},
  researchAreas = {drug-discovery, experiment-automation},
  researchArea = {drug-discovery},
  featured = {true},
  highlight = {Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling.},
  citations = {44}
}

Related Research Areas

Related Publications

2022
cited 74

Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds

Korshunova M., Huang N., Capuzzi S., Radchenko D. S., Savych O., Moroz Y. S., Wells C. I., Willson T. M., Tropsha A., Isayev O.

Communications Chemistry 5

Generative AI Drug Discovery Experiment Automation

AbstractDeep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties.

DOI
2025

Discovery of Novel Celecoxib Polymorphs Using AIMNet2 Machine Learning Interatomic Potential

Zheng P., Abramov Y., Sun C. C., Isayev O.

Machine Learning Potentials Experiment Automation Drug Discovery Materials Informatics

Polymorphism plays a pivotal role in defining the solid-state properties of pharmaceutical compounds, yet the discovery and accurate energy ranking of polymorphs remain a challenge.

DOI
2024
cited 17

In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations

Gutkin E., Gusev F., Gentile F., Ban F., Koby S. B., Narangoda C., Isayev O., Cherkasov A., Kurnikova M. G.

Chemical Science 15 , 8800–8812

Drug Discovery Experiment Automation

In this work, we combined Deep Docking and free energy MD simulations for the in silico screening and experimental validation for potential inhibitors of leucine rich repeat kinase 2 (LRRK2) targeting the WD40 repeat (WDR) domain.

DOI
2021
cited 6

A Bag of Tricks for Automated De Novo Design of Molecules with the Desired Properties: Application to EGFR Inhibitor Discovery

Korshunova M., Huang N., Capuzzi S., Radchenko D. S., Savych O., Moroz Y. S., Wells C., Willson T. M., Tropsha A., Isayev O.

Generative AI Drug Discovery Experiment Automation

Deep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties.

DOI
2020
cited 212

The ANI-1ccx and ANI-1x data sets, coupled-cluster and density functional theory properties for molecules

Smith J. S., Zubatyuk R., Nebgen B., Lubbers N., Barros K., Roitberg A. E., Isayev O., Tretiak S.

Scientific Data 7

Machine Learning Potentials Quantum Chemistry Experiment Automation

Abstract Maximum diversification of data is a central theme in building generalized and accurate machine learning (ML) models.

DOI